RIGL
Rigel Pharmaceuticals Inc
NASDAQ: RIGL · HEALTHCARE · BIOTECHNOLOGY
$29.22
-4.38% today
Updated 2026-04-29
Market cap
$564.75M
P/E ratio
1.57
P/S ratio
1.92x
EPS (TTM)
$19.48
Dividend yield
—
52W range
$17 – $52
Volume
0.4M
WallStSmart proprietary scores
79
out of 100
Grade: B+
Buy
Investment rating
9.3
Growth
A+5.0
Quality
C+10.0
Profitability
A+8.3
Valuation
A—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$51.20
+75.22%
12-Month target
$32.39
+10.85%
Intrinsic (DCF)
$294.92
Margin of safety
+88.15%
0 Strong Buy3 Buy2 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Profit margin 124.70% — above average
+ ROE 185.90% — strong efficiency
+ Free cash flow $21.97M — positive
+ Revenue growth 21.20% QoQ
+ 88.15% below intrinsic value
Risks
No major risks identified
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $120.24M | $116.88M | $179.28M | $294.28M | $294.28M |
| Net income | $-58.57M | $-25.09M | $17.48M | $367.02M | $268.06M |
| EPS | — | — | — | — | $19.48 |
| Free cash flow | $-74.21M | $-20.74M | $31.07M | $75.66M | $21.97M |
| Profit margin | -48.71% | -21.47% | 9.75% | 124.72% | 124.70% |
Peer comparison
Smart narrative
Rigel Pharmaceuticals Inc trades at $29.22. representing a P/E of 1.57x trailing earnings. Our Smart Value Score of 79/100 indicates the stock is good. TTM revenue stands at $294.28M. with profit margins at 124.70%. Our DCF model estimates intrinsic value at $294.92.
Frequently asked questions
What is Rigel Pharmaceuticals Inc's stock price?
Rigel Pharmaceuticals Inc (RIGL) trades at $29.22.
Is Rigel Pharmaceuticals Inc overvalued?
Smart Value Score 79/100 (Grade B+, Buy). DCF value $294.92.
What is the price target of Rigel Pharmaceuticals Inc (RIGL)?
The analyst target price is $51.20, representing +75.2% upside from the current price of $29.22.
What is the intrinsic value of Rigel Pharmaceuticals Inc (RIGL)?
Based on our DCF model, intrinsic value is $294.92, a +88.2% margin of safety versus $29.22.
What is the future stock price of RIGL by 2030?
Our revenue-driven model estimates Rigel Pharmaceuticals Inc could reach $54.79 by 2030, based on historical CAGR, margin trends, and capped P/E multiples.
What is Rigel Pharmaceuticals Inc's revenue?
TTM revenue is $294.28M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.92x
ROE185.90%
Beta1.27
50D MA$29.98
200D MA$34.01
Shares out0.02B
Float0.02B
Short ratio—
Avg volume0.4M
Performance
1 week-5.51%
1 month+18.21%
3 months-18.09%
YTD-28.76%
1 year—
3 years—
5 years—